Loading patent…
AssigneeTissuetech, Inc.
InventorsScheffer TSENG, Hua HE, Wei LI
Estimating the term…
Compositions having a combination of specific biological components have been found to exert a number of useful effects in mammalian cells, including modulating TGF β signaling, apoptosis, and proliferation of mammalian cells, as well as decreasing inflammation in mice. These components can be obtained commercially, or can be prepared from biological tissues such as placental tissues. Placental amniotic membrane (AM) preparations described herein include AM pieces, AM extracts, AM jelly, AM stroma, and mixtures of these compositions with additional components. The compositions can be used to treat various diseases, such as wound healing, inflammation and angiogenesis-related diseases.
-10. (canceled)
A method of reducing inflammation in an individual in need thereof, comprising administering ground or pulverized amniotic membrane derived from frozen or previously frozen placental material.
A method of reducing inflammation in an individual in need thereof, comprising administering a composition comprising ground or pulverized amniotic membrane derived from frozen or previously frozen placental material.
Dependencies are inferred from the claim text.